NCT06011200View on ClinicalTrials.gov

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 16, 2023

Primary Completion Date

December 11, 2023

Study Completion Date

May 11, 2024

Conditions
Epidemic Meningitis
Interventions
BIOLOGICAL

MCV4

1 dose of MCV4 on Day 0

BIOLOGICAL

MSPV4

1 dose of MSPV4 on Day 0

Trial Locations (1)

Unknown

Shanyang County Center for Disease Prevention and Control, Shanyang

Sponsors
All Listed Sponsors
lead

CanSino Biologics Inc.

INDUSTRY

NCT06011200 - A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population | Biotech Hunter | Biotech Hunter